Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55

Benzinga Newsdesk www.benzinga.com Positive 70.3%

Neg 0% Neu 0% Pos 70.3%

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.